On August 21, 2019 Mallinckrodt Pharmaceuticals (NYSE: MNK), a global biopharmaceutical company, reported that it will present on Tuesday, Sept. 10, 2019, at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt, 109 E. 42nd St., New York (Press release, Mallinckrodt, AUG 21, 2019, View Source [SID1234538921]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bryan Reasons, Executive Vice President and Chief Financial Officer, and Steven Romano, M.D., Executive Vice President and Chief Scientific Officer, will represent the company in a fireside chat at 8:00 a.m. Eastern.

Individuals who cannot attend the meeting in person can find webcast information at: http://www.mallinckrodt.com/investors. A replay will also be available following the meeting.